Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes.
Dou Y, Cha DJ, Franklin JL, Higginbotham JN, Jeppesen DK, Weaver AM, Prasad N, Levy S, Coffey RJ, Patton JG, Zhang B. · 2016
Read Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes. by Dou Y, Cha DJ, Franklin JL, Higginbotham JN, Jeppesen DK, Weaver AM, Prasad N, Levy S, Coffey RJ, Patton JG, Zhang B. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5125100.txt.
Introduction
Yongchao Dou and ten co-authors studied circular RNAs in colon cancer in Scientific Reports in 2016. Circular RNAs are loops of RNA, once dismissed as splicing errors, now known to be common and cell-specific. The team compared colon cancer cell lines that differ only in whether the KRAS gene is normal or mutated.
Across hundreds of loop candidates found by their analysis pipeline, circular RNAs were broadly turned down in cells carrying mutant KRAS, a result repeated in a second pair of cell lines. The loops also appeared in the vesicles the cells shed, and were richer there than inside the cells. Because mutant KRAS drives many colon cancers, the authors propose circular RNAs as candidate cancer markers worth developing.
Catalog record
| CREATOR | Dou Y, Cha DJ, Franklin JL, Higginbotham JN, Jeppesen DK, Weaver AM, Prasad N, Levy S, Coffey RJ, Patton JG, Zhang B. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes By Yongchao Dou, Diana J. Cha, Jeffrey L. Franklin, James N. Higginbotham, Dennis K. Jeppesen, Alissa M. Weaver, Nripesh Prasad, Shawn Levy, Robert J. Coffey, James G. Patton, Bing Zhang Published in: Scientific Reports DOI: 10.1038/srep37982 ABSTRACT Recent studies have shown that circular RNAs (circRNAs) are abundant, widely expressed in mammals, and can display cell-type specific expression. However, how production of circRNAs is regulated and their precise biological function remains largely unknown. To study how circRNAs might be regulated during colorectal cancer progression, we used three isogenic colon cancer cell lines that differ only in KRAS mutation status. Cellular RNAs from the parental DLD-1 cells that contain both wild-type and G13D mutant KRAS alleles and isogenically-matched derivative cell lines, DKO-1 (mutant KRAS allele only) and DKs-8 (wild-type KRAS allele only) were analyzed using RNA-Seq. We developed a bioinformatics pipeline to identify and evaluate circRNA candidates from RNA-Seq data. Hundreds of high-quality circRNA candidates were identified in each cell line. Remarkably, circRNAs were significantly down-regulated at a global level in DLD-1 and DKO-1 cells compared to DKs-8 cells, indicating a widespread effect of mutant KRAS on circRNA abundance. This finding was confirmed in two independent colon cancer cell lines HCT116 (KRAS mutant) and HKe3 (KRAS WT). In all three cell lines, circRNAs were also found in secreted extracellular-vesicles, and circRNAs were more abundant in exosomes than cells. Our results suggest that circRNAs may serve as promising cancer biomarkers. Circular RNAs (circRNAs) were first reported more than 30 years ago1234, but had long been perceived as occasional RNA splicing errors until recent genome-wide analyses powered by next generation sequencing (NGS) technologies have shown these are bona fide RNA species. Studies during the past several years have identified a large number of exonic and intronic circRNAs across the eukaryotic lineage, including human, mouse, zebrafish, worms, fungi, and plants5678. Based on the assumption that the abundance of circRNAs is much lower than that of linear RNAs, early studies typically use RNase R, a magnesium-dependent 3′ to 5′ exoribonuclease, to deplete linear RNAs before sequencing9. However, recent work showed that the abundance of circRNAs is similar to or higher than that of linear transcripts for about one in eight human genes10, which can be partially explained by higher cellular stability and longer half-life of circRNAs compared to linear mRNAs11. The observed high abundance of circRNAs suggests that RNase R treatment is likely to be unnecessary in NGS-based analysis of circRNAs, consistent with the identification of 7112 circRNA candidates from non-poly(A)-selected libraries generated by the ENCODE project1213. It is now clear that circRNAs are evolutionarily conserved, exhibit cell-specific expression patterns, and are regulated independent of their linear transcripts101415. For example, circRNAs are enriched in brain and accumulate to the highest levels in the aging central nervous system1617. Recent studies also showed that circRNAs can be transferred to human exosomes18, where they are enriched and stable19. These findings suggest that circRNAs are prevalent, abundant, and potentially functional. Knowledge about the general sequence features, biogenesis, and putative functions of circRNAs, especially exonic circRNAs, has gradually accumulated11. Because both circRNAs and linear RNAs are spliced from pre-mRNAs, the competition between circularization and linear splicing may play a role in the regulation of gene expression20. Moreover, introns between exons may be retained when exons are circularized21. Circularization of exonic circRNAs typically involves the canonical GU-AG splice site pairs22 and can contain one or multiple exons. On average, single-exon circRNAs form with exons that are three times longer than non-circularized exons10. Exon circularization is promoted by pairing of reverse complementary sequences within introns bracketing circRNAs; reverse complimentary sequences are primarily Alu repeats232425. Two possible mechanisms for the formation of exonic circRNAs have been proposed, and both involve the canonical spliceosome11. Two circRNAs in mammals have been shown to function as miRNA sponges5, but significant enrichment of miRNA binding sites was not found for the majority of circRNA candidates1213. Although other non-coding RNAs have been shown to play critical roles in cancer, the association between circRNAs and cancer is largely unknown262728. In this study, we performed deep RNA-Seq analysis of rRNA-depleted total RNA libraries to characterize circRNA expression in three isogenically-matched human colon cancer cell lines that differ only in the mutation status of the KRAS oncogene. The parental DLD-1 cells contain both wild-type and G13D mutant KRAS alleles, whereas the isogenically-matched derivative cell lines DKO-1 and DKs-8 contain only a mutant KRAS and a wild-type KRAS allele, respectively. KRAS mutations occur in approximately 34–45% of colon cancers2930 and have been associated with a wide range of tumor-promoting effects31. We developed an integrated bioinformatics pipeline to identify, confirm and annotate circRNAs based on RNA-Seq data. Using the pipeline, we studied both cellular and exosomal circRNAs in the three cell lines, with confirmation of altered circRNAs in a second set of isogenically matched cell lines. To our knowledge, this is the first report describing the impact of a well-established oncogene on the abundance of circRNAs. RESULTS Bioinformatics pipeline Exonic circRNAs largely result from back-spliced exons, in which splice junctions are formed by an upstream 5′ splice acceptor and a downstream 3′ splice donor. Back-splice reads mapping to such junctions are the most important indicator for circRNAs that can be gleaned from RNA-Seq data51116233233. Similar to the existing pipeline used by Memczak et al.5, our pipeline (Fig. 1A) uses the presence of back-splice reads to identify exonic circRNA candidates. However, multiple mapping positions are allowed when mapping anchors in our pipeline. Find-circ only reports a random mapping position and may therefore miss some circRNAs (false negatives). Moreover, because one read may be considered as a back-splicing candidate at one position or a linear gapped mapping at another position, find-circ may also introduce false positives. Thus, allowing multiple mapping position in our pipeline may help reduce both false positives and false negatives. Briefly, one paired-end read was used as two single-end reads for mapping to the genome. Mappable reads were discarded because back-splice reads cannot be mapped to the genome directly. The 5′ and 3′ termini of unmapped reads were then extracted as anchors, which were aligned to the genome independently with multiple mapping allowed. Because multiple mapping is allowed, all possible pairs of anchor alignments were evaluated. If any of these pairs correspond to a normal linear gapped mapping, the read was discarded. For the remaining reads, all the possible extensions that could be extended to reconstruct the original read with a maximum of two mismatches were further considered. Then we will search the GU/AC splice sites for each extension. If any extensions with the GU/AC splice sites, the read was considered as with GU/AC splice sites. Extended alignments flanked by GU/AG splice sites were used to define a back-splice read. Contamination from other biological sources may affect both the identification and quantification of circRNAs. To check possible contaminations from bacteria and viruses, we built a database with all bacterial and viral sequences and blasted all back-splicing mates against the database. For cellular RNAs, 99.6% to 99.8% of the mates had no hits to the database and none of them had a hit with two or less mismatches.